Table of Contents

Executive Summary

1 Industry Overview of Oncolytic Virus

• 1.1 Definition of Oncolytic Virus
• 1.2 Oncolytic Virus Segment by Type
  • 1.2.1 Global Oncolytic Virus Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 HSV-based Oncolytic Viruses
  • 1.2.3 Adenoviruses-based Oncolytic Viruses
  • 1.2.4 Vaccinia Virus-based Oncolytic Viruses
  • 1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
  • 1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
• 1.3 Oncolytic Virus Segment by Applications
  • 1.3.1 Global Oncolytic Virus Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Pharmaceutical
  • 1.3.3 Health Care
  • 1.3.4 Commerical
• 1.4 Global Oncolytic Virus Overall Market
  • 1.4.1 Global Oncolytic Virus Revenue (2014-2025)
  • 1.4.2 Global Oncolytic Virus Production (2014-2025)
  • 1.4.3 North America Oncolytic Virus Status and Prospect (2014-2025)
  • 1.4.4 Europe Oncolytic Virus Status and Prospect (2014-2025)
  • 1.4.5 China Oncolytic Virus Status and Prospect (2014-2025)
  • 1.4.6 Japan Oncolytic Virus Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Oncolytic Virus Status and Prospect (2014-2025)
  • 1.4.8 India Oncolytic Virus Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Oncolytic Virus
• 2.3 Manufacturing Process Analysis of Oncolytic Virus
• 2.4 Industry Chain Structure of Oncolytic Virus

3 Development and Manufacturing Plants Analysis of Oncolytic Virus

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Oncolytic Virus Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Oncolytic Virus
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Oncolytic Virus Production and Capacity Analysis
• 4.2 Oncolytic Virus Revenue Analysis
• 4.3 Oncolytic Virus Price Analysis
• 4.4 Market Concentration Degree

5 Oncolytic Virus Regional Market Analysis

• 5.1 Oncolytic Virus Production by Regions
  • 5.1.1 Global Oncolytic Virus Production by Regions
  • 5.1.2 Global Oncolytic Virus Revenue by Regions
• 5.2 Oncolytic Virus Consumption by Regions
• 5.3 North America Oncolytic Virus Market Analysis
  • 5.3.1 North America Oncolytic Virus Production
  • 5.3.2 North America Oncolytic Virus Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Oncolytic Virus Import and Export
• 5.4 Europe Oncolytic Virus Market Analysis
  • 5.4.1 Europe Oncolytic Virus Production
  • 5.4.2 Europe Oncolytic Virus Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Oncolytic Virus Import and Export
• 5.5 China Oncolytic Virus Market Analysis
  • 5.5.1 China Oncolytic Virus Production
  • 5.5.2 China Oncolytic Virus Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Oncolytic Virus Import and Export
• 5.6 Japan Oncolytic Virus Market Analysis
  • 5.6.1 Japan Oncolytic Virus Production
  • 5.6.2 Japan Oncolytic Virus Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Oncolytic Virus Import and Export
• 5.7 Southeast Asia Oncolytic Virus Market Analysis
  • 5.7.1 Southeast Asia Oncolytic Virus Production
  • 5.7.2 Southeast Asia Oncolytic Virus Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Oncolytic Virus Import and Export
• 5.8 India Oncolytic Virus Market Analysis
  • 5.8.1 India Oncolytic Virus Production
  • 5.8.2 India Oncolytic Virus Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Oncolytic Virus Import and Export

6 Oncolytic Virus Segment Market Analysis (by Type)

• 6.1 Global Oncolytic Virus Production by Type
• 6.2 Global Oncolytic Virus Revenue by Type
• 6.3 Oncolytic Virus Price by Type

7 Oncolytic Virus Segment Market Analysis (by Application)

• 7.1 Global Oncolytic Virus Consumption by Application
• 7.2 Global Oncolytic Virus Consumption Market Share by Application (2014-2019)

8 Oncolytic Virus Major Manufacturers Analysis

• 8.1 Merck
  • 8.1.1 Merck Oncolytic Virus Production Sites and Area Served
  • 8.1.2 Merck Product Introduction, Application and Specification
  • 8.1.3 Merck Oncolytic Virus Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Otsuka Pharmaceutical Co
  • 8.2.1 Otsuka Pharmaceutical Co Oncolytic Virus Production Sites and Area Served
  • 8.2.2 Otsuka Pharmaceutical Co Product Introduction, Application and Specification
  • 8.2.3 Otsuka Pharmaceutical Co Oncolytic Virus Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Pfizer
  • 8.3.1 Pfizer Oncolytic Virus Production Sites and Area Served
  • 8.3.2 Pfizer Product Introduction, Application and Specification
  • 8.3.3 Pfizer Oncolytic Virus Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Roche
  • 8.4.1 Roche Oncolytic Virus Production Sites and Area Served
  • 8.4.2 Roche Product Introduction, Application and Specification
  • 8.4.3 Roche Oncolytic Virus Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Cold Genesys
  • 8.5.1 Cold Genesys Oncolytic Virus Production Sites and Area Served
  • 8.5.2 Cold Genesys Product Introduction, Application and Specification
  • 8.5.3 Cold Genesys Oncolytic Virus Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Genelux
  • 8.6.1 Genelux Oncolytic Virus Production Sites and Area Served
  • 8.6.2 Genelux Product Introduction, Application and Specification
  • 8.6.3 Genelux Oncolytic Virus Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Latima
  • 8.7.1 Latima Oncolytic Virus Production Sites and Area Served
  • 8.7.2 Latima Product Introduction, Application and Specification
  • 8.7.3 Latima Oncolytic Virus Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Neotropix
  • 8.8.1 Neotropix Oncolytic Virus Production Sites and Area Served
  • 8.8.2 Neotropix Product Introduction, Application and Specification
  • 8.8.3 Neotropix Oncolytic Virus Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Shanghai Sunway Biotech
  • 8.9.1 Shanghai Sunway Biotech Oncolytic Virus Production Sites and Area Served
  • 8.9.2 Shanghai Sunway Biotech Product Introduction, Application and Specification
  • 8.9.3 Shanghai Sunway Biotech Oncolytic Virus Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 SillaJen
  • 8.10.1 SillaJen Oncolytic Virus Production Sites and Area Served
  • 8.10.2 SillaJen Product Introduction, Application and Specification
  • 8.10.3 SillaJen Oncolytic Virus Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Takara Bio
• 8.12 Theravir

9 Development Trend of Analysis of Oncolytic Virus Market

• 9.1 Global Oncolytic Virus Market Trend Analysis
  • 9.1.1 Global Oncolytic Virus Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Oncolytic Virus Regional Market Trend
  • 9.2.1 North America Oncolytic Virus Forecast 2019-2025
  • 9.2.2 Europe Oncolytic Virus Forecast 2019-2025
  • 9.2.3 China Oncolytic Virus Forecast 2019-2025
  • 9.2.4 Japan Oncolytic Virus Forecast 2019-2025
  • 9.2.5 Southeast Asia Oncolytic Virus Forecast 2019-2025
  • 9.2.6 India Oncolytic Virus Forecast 2019-2025
• 9.3 Oncolytic Virus Market Trend (Product Type)
• 9.4 Oncolytic Virus Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Oncolytic Virus Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

The global Oncolytic Virus market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Oncolytic Virus volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oncolytic Virus market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Oncolytic Virus in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Oncolytic Virus manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merck
Otsuka Pharmaceutical Co
Pfizer
Roche
Cold Genesys
Genelux
Latima
Neotropix
Shanghai Sunway Biotech
SillaJen
Takara Bio
Theravir

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses

Segment by Application
Pharmaceutical
Health Care
Commerical